Overview

Phase IV Clinical Trial to Evaluate the Efficacy and Safety of PlbCR and Aceclofenac in the Treatment of Patients With Osteoarthritis of the Knee

Status:
Completed

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

A multicenter, randomized, double-blinded, parallel, active-controlled, phase IV clinical trial to evaluate the efficacy and safety of PlbCR and aceclofenac in the treatment of patients with osteoarthritis of the knee

Phase:

Phase 4

Details

Lead Sponsor:

Daewon Pharmaceutical Co., Ltd.

Treatments:

Aceclofenac